Do alternative methods of measuring tumor size, including consideration of multicentric/multifocal disease, enhance prognostic information beyond TNM staging in women with early stage breast cancer: an analysis of the NCIC CTG MA.5 and MA.12 clinical trials

Publication | Closed Access

DOI

Citations

References

2013

Year

John Hilton, N. Bouganim, Bin Dong, Judith‐Anne W. Chapman, Angel Arnaout, F P O’Malley, Karen A. Gelmon, Rinat Yerushalmi, Mark N. Levine, V. Bramwell,

Breast Cancer Research and Treatment

Breast OncologyNcic Ctg Ma.5Ma.12 Clinical TrialsMedicineTumor SizeBreast ImagingBreast CancerOncologyRadiation OncologyCancer ResearchRadiologyHealth Sciences